Document is current
Any future updates will be listed below
-
Authors
Wimberger, Sandra https://orcid.org/0000-0003-0541-7780
Akrap, Nina
Firth, Mike
Brengdahl, Johan
Engberg, Susanna
Schwinn, Marie K.
Slater, Michael R. https://orcid.org/0000-0002-2803-0338
Lundin, Anders https://orcid.org/0000-0003-3131-8022
Hsieh, Pei-Pei
Li, Songyuan
Cerboni, Silvia
Sumner, Jonathan
Bestas, Burcu https://orcid.org/0000-0003-3990-1909
Schiffthaler, Bastian
Magnusson, Björn
Di Castro, Silvio
Iyer, Preeti
Bohlooly-Y, Mohammad
Machleidt, Thomas
Rees, Steve
Engkvist, Ola https://orcid.org/0000-0003-4970-6461
Norris, Tyrell
Cadogan, Elaine B. https://orcid.org/0000-0002-9757-8305
Forment, Josep V.
Šviković, Saša https://orcid.org/0000-0002-4149-8453
Akcakaya, Pinar
Taheri-Ghahfarokhi, Amir
Maresca, Marcello https://orcid.org/0000-0003-0796-661X
-
Funding
Funding for this research was provided by:
EC | Horizon 2020 Framework Programme (765269)
AstraZeneca R&D postdoc program
AstraZeneca R&D postdoc program
AstraZeneca R&D postdoc program
AstraZeneca R&D postdoc program
- License Information
-
More Information
Article History
Received: 26 January 2023
Accepted: 25 July 2023
First Online: 14 August 2023
Competing interests
: S.W., N.A., M.F., J.B., S.E., A.L., P.H., S.L., S.C., J.S., B.B., B.S., B.M., S.DC., P.I., M.B., T.M., S.R., O.E., E.B.C., J.V.F., S.Š., P.A., A.T.G. and M.M. are presently or were previously employed by AstraZeneca and may be AstraZeneca shareholders. M.K.S., M.R.S. and TM are presently employed by Promega Corporation. S.W., N.A., S.Š. and M.M. are listed as co-inventors in an AstraZeneca patent (WO2023052508A2) related to this work.
